Functional In Vivo MHC Class II Loading by Endogenously Synthesized Glycoprotein During Viral Infection

Journal of Immunology

Volumn 158, Issue 12, 1997, Pages 5717-5726

  Oxenius, Annette ^a,d   Bachmann, Martin F ^b   Mathis, Diane ^c   Benoist, Christophe ^c   Zinkernagel, Rolf M ^a   Hengartner, Hans ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^d INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MEMBRANE PROTEIN;

ANIMAL; ARTICLE; C57BL MOUSE; GENE; GENETICS; HELPER CELL; IMMUNOLOGY; MOUSE; PHYSIOLOGY; T LYMPHOCYTE; VIRUS MENINGITIS;

ANIMALS; EPITOPES; GENES, MHC CLASS II; LYMPHOCYTIC CHORIOMENINGITIS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0031570535     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Germain, R. N. 1986. The ins and outs of antigen processing and presentation. Nature 322:687.
2. Ciechanover, A. 1994. The ubiquitin-proteasome proteolytic pathway. Cell 79: 13.
3. Braciale, T. J. 1992. Antigen processing for presentation by MHC class I molecules. Curr. Opin. Immunol. 4:59.
4. Link Snyder, H., J. W. Yewdell, and J. Bennink. 1994. Trimming of antigenic peptides in early secretory compartments. J. Exp. Med. 180:2347.
5. Bacik, I., J. H. Cox, R. Anderson, J. W. Yewdell, and J. R. Bennink. 1994. TAP (transporter associated with antigen processing): independent presentation of endogenously synthesized peptides is enhanced by endoplasmatic reticulum insertion sequences located at the amino-but not carboxyl-terminus of the peptide. J. Immunol. 152:381.
6. Roelse, J., M. Grommé, F. Momburg, G. Hämmerling, and J. Neefjes. 1994. Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling. J. Exp. Med. 180:1591.
7. Peters, P. J., J. J. Neefjes, V. Oorschot, H. L. Ploegh, and H. J. Geuze. 1991. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature 349:669.
8. Cresswell, P. 1992. Chemistry and functional role of the invariant chain. Curr. Biol. 4:87.
9. Neefjes, J. J., V. Stollorz, P. J. Peters, H. J. Geuze, and H. L. Ploegh. 1990. The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell 61:171.
10. Guagliardi, L. E., B. Koppelman, J. S. Blum, M. S. Marks, P. Cresswell, and F. M. Brodsky. 1990. Co-localization of molecules involved in antigen processing and presentation in early endocytic compartment. Nature 343:133.
11. Harding, C. V., R. W. Roof, and E. R. Unanue. 1989. Turnover of Ia peptide complexes is facilitated in viable antigen-presenting cells: biosynthetic turnover of Ia vs. peptide exchange. Proc. Natl. Acad. Sci. USA 86:4230.
12. Cresswell, P. 1985. Intracellular class II HLA antigens are accessible to transferrin-neuramidase conjugates internalized by receptor-mediated endocytosis. Proc. Natl. Acad. Sci. USA 82:8188.
13. Lamb, C. A., J. W. Yewdell, J. R. Bennink, and P. Cresswell. 1991. Invariant chain targets HLA class II molecules to acidic endosomes containing internalized influenza virus. Proc. Natl. Acad. Sci. USA 88:5998.
14. Busch, R., I. Y. Vturina, J. Drexler, F. Momburg, and G. J. Hämmerling. 1995. Poor loading of major histocompatibilily complex class II molecules with endogenously synthesized short peptides in the absence of invariant chain. Eur. J. Immunol. 25:48.
15. Roche, P. A., M. S. Marks, and P. Cresswell. 1991. Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature 354:392.
16. Bakke, O., and B. Dobberstein. 1990. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 63:707.
17. Germain, R. N. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76:287.
18. Sant, A. J., and J. Miller. 1994. MHC class II antigen processing: biology of invariant chain. Curr. Opin. Immunol. 6:57.
19. Stockinger, B., U. Pessara, R. H. Lin, J. Habicht, M. Grez, and N. Koch. 1989. A role of Ia-associated invariant chains in antigen processing and presentation. Cell 56:684.
20. Roche, P. A. 1995. HLA-DM: an in vitro facilitator of MHC class II peptide loading. Immunity 3:259.
21. Sherman, M. A., D. A. Weber, and P. E. Jensen. 1995. DM enhances peptide loading to class II MHC by release of invariant chain-derived peptide. Immunity 3:197.
22. Denzin, L. K., and P. Cresswell. 1995. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 82:155.
23. Harding, C. V., C. F. Leyva, and E. R. Unanue. 1988. Mechanisms of antigen processing. Immunol. Rev. 106:77.
24. McCoy, K. L., and R. H. Schwartz. 1988. The role of intracellular acidification in antigen processing. Immunol. Rev. 106:129.
25. Germain, R. N., and D. H. Margulies. 1993. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:403.
26. Jin, Y., W. K. Shih, and I. Berkower. 1988. Human T cell response to the surface antigen of hepatitis B virus (HBsAg): endosomal and nonendosomal processing pathways are accessible to both endogenous and exogenous antigen. J. Exp. Med. 168:293.
27. Weiss, S., and B. Bogen. 1991. MHC class II-restricted presentation of intracellular antigen. Cell 64:767.
28. Weiss, S., and B. Bogen. 1989. B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells. Proc. Natl. Acad. Sci. USA 86:282.
29. Sekaly, R. P., S. Jacobson, J. R. Richert, C. Tonnelle, H. F. McFarland, and E. O. Long. 1988. Antigen presentation to HLA class II-restricted measles virus-specific T-cell clones can occur in the absence of the invariant chain. Proc. Natl. Acad. Sci. USA 85:1209.
30. Jacobson, S., R. P. Sekaly, C. L. Jacobson, H. H. McFarland, and E. O. Long. 1989. HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells. J. Virol. 63:1756.
31. Nuchtern, J. G., W. E. Biddison, and R. D. Klausner. 1990. Class II MHC molecules can use the endogenous pathway of antigen presentation. Nature 343:74.
32. Malnati, M. S., M. Marti, T. LaVaute, D. Jaraquemada, W. Biddison, R. DeMars, and E. O. Long. 1992. Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells. Nature 357:702.
33. Jaraquemada, D., M. Marti, and E. O. Long. 1990. An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells. J. Exp. Med. 172:947.
34. Dodi, A. I., S. Brett, T. Nordeng, S. Sidhu, R. J. Batchelor, G. Lombardi, O. Bakke, and R. I. Lechler. 1994. The invariant chain inhibits presentation of endogenous antigens by a human fibroblast cell line. Eur. J. Immunol. 24:1632.
35. Brooks, A., S. Hartley, L. Kier-Nielsen, J. Perera, C. C. Goodnow, A. Basten, and J. McCluskey. 1991. Class II-restricted presentation of an enogenously derived immunodominant T-cell determinant of hen egg lysozyme. Proc. Natl. Acad. Sci. USA 88:3290.
36. Rudensky, A. Y., P. Preston-Hurlburt, S. C. Hong, A. Barlow, and C. A. Janeway. 1991. Sequence analysis of peptides bound to MHC class II molecules. Nature 353:622.
37. Rudensky, A., S. Rath, P. Preston-Hurlburt, D. B. Murphy, and C. A. Janeway. 1991. On the complexity of self. Nature 353:660.
38. Chen, B. P., A. Madrigal, and P. Parham. 1990. Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule. J. Exp. Med. 172:779.
39. Newcomb, J. R., and P. Cresswell. 1993. Characterization of peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated αβ dimers. J. Immunol. 150:499.
40. Moreno, J., D. A. A. Vignali, F. Nadimi, S. Fuchs, L. Adorini, and G. J. Haemmerling. 1991. Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen. J. Immunol. 147:3306.
41. Bodmer, H., S. Viville, C. Benoist, and D. Mathis. 1994. Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain. Science 263:1284.
42. + T cell recognition. J. Exp. Med. 171:875.
43. Van Binnendijk, R. S., C. A. van Baalen, M. C. M. Poelen, P. de Vries, J. Boes, V. Cerundolo, A. D. M. E. Osterhaus, and F. G. C. M. UytdeHaag. 1992. Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I-and class II-restricted cytotoxic T cell recognition. J. Exp. Med. 176:119.
44. Pinet, V., M. S. Malnati, and E. O. Long. 1994. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen. J. Immunol. 152:4852.
45. Oxenius, A., M. F. Bachmann, P. G. Ashton-Rickardt, S. Tonegawa, R. M. Zinkernagel, and H. Hengartner. 1995. Presentation of endogenous viral proteins in association with major histocompatibility complex II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system. Eur. J. Immunol. 25:3402.
46. Aichinger, G., and R. I. Lechler. 1995. Endogenous pathway of class II presentation. Biochem. Soc. Trans. 23:657.
47. Bikoff, E. K. 1992. Formation of complexes between self-peptides and MHC class II molecules in cells defective for presentation of exogenous protein antigens. J. Immunol. 149:1.
48. Viville, S., J. Neefjes, V. Lotteau, A. Dierich, M. LeMeur, H. Ploegh, C. Benoist, and D. Mathis. 1993. Mice lacking the MHC class II-associated invariant chain. Cell 72:635.
49. Matsuura, Y., R. D. Possee, H. A. Overton, and D. H. L. Bishop. 1987. Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins. J. Gen. Virol. 68:1233.
50. Bachmann, M. F., T. M. Kündig, G. Freer, Y. Li, D. H. Bishop, H. Hengartner, and R. M. Zinkernagel. 1994. Induction of protective cytotoxic T cells with viral proteins. Eur. J. Immunol. 24:2128.
51. + T lymphocyte-mediated antiviral immunity in mice as a result of injection of recombinant viral proteins. J. Immunol. 153:2554.
52. Pruslin, F. H. 1991. Caveats and suggestions for the ELISA. J. Immunol. Methods 137:27.
53. Chirmule, N. 1991. Misinterpretation of results of cytokine bioassays. J. Immunol. Methods 137:141.
54. Battegay, M., D. Moskophidis, H. Waldner, M. A. Bründler, Fung, W. P. Leung, T. W. Mak, H. Hengartner, and R. M. Zinkernagel. 1993. Impairment and delay of neutralizing antiviral antibody responses by virus specific cytotoxic T cells. J. Immunol. 151:5408.
55. Battegay, M., S. Cooper, A. Althage, J. Baenziger, H. Hengartner, and R. M. Zinkernagel. 1991. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24 or 96 well plates. J. Virol. Methods 33:191.
56. Buchmeier, M. J., J. H. Elder, and M. Oldstone. 1978. Protein structure of lymphocytic choriomeningitis virus: identification of the viral structural and cell associated polypeptides. Virology 89:133.
57. Vezza, A. C., G. P. Gard, R. W. Compans, and D. R. L. Bishop. 1977. Structural components of the arenavirus Pichinde. J. Virol. 23:776.
58. Buchmeier, M. J., R. M. Welsh, F. J. Dutko, and M. B. A. Oldstone. 1980. The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv. Immunol. 30:275.
59. Tourne, S., N. Nakano, S. Viville, C. Benoist, and D. Mathis. 1995. The influence of invariant chain on the positive selection of single T cell receptor specificities. Eur. J. Immunol. 25:1851.
60. + T cell selection in mice lacking invariant chain expression. J. Exp. Med. 177:1699.
61. Battegay, M., M. F. Bachmann, C. Burkhart, S. Viville, C. Benoist, D. Mathis, H. Hengartner, and R. M. Zinkernagel. 1996. Antiviral immune response of mice lacking MHC class II or its associated invariant chain. Cell Immunol. 167:115.
62. Lehmann, G. F. 1971. Lymphocytic choriomeningitis virus. Virol. Monogr. 10:1.
63. Kyburz, D., D. E. Speiser, M. Battegay, H. Hengartner, and R. M. Zinkernagel. 1993. Lysis of infected cells in vivo by anti-viral cytolytic T-cells demonstrated by release of cell internal viral proteins. Eur. J. Immunol. 23:1540.
64. Bachmann, M. F., U. Hoffmann Rohrer, T. M. Kündig, K. Bürki, H. Hengartner, and R. M. Zinkernagel. 1993. The influence of antigen organization on B cell responsiveness. Science 262:1448.
65. Bachmann, M. F., and T. M. Kündig. 1994. In vivo versus in vitro assays for assessment of T-and B-cell function. Curr. Opin. Immunol. 6:320.
66. Shachar, I., and R. A. Flavell. 1996. Requirement for invariant chain in B cell maturation and function. Science 247:106.